Blurbs

Analysts Are Bullish on Top Healthcare Stocks: Centene (CNC), Replimune Group (REPL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Centene (CNCResearch Report) and Replimune Group (REPLResearch Report) with bullish sentiments.

Centene (CNC)

In a report released yesterday, David Windley from Jefferies maintained a Buy rating on Centene, with a price target of $116.00. The company’s shares closed last Tuesday at $93.15, close to its 52-week high of $94.58.

According to TipRanks.com, Windley is a top 100 analyst with an average return of 15.2% and a 69.9% success rate. Windley covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Molina Healthcare, and Stevanato Group.

Centene has an analyst consensus of Strong Buy, with a price target consensus of $101.17, implying a 9.2% upside from current levels. In a report issued on July 14, Truist Financial also maintained a Buy rating on the stock with a $102.00 price target.

See the top stocks recommended by analysts >>

Replimune Group (REPL)

In a report issued on July 25, Jonathan Chang from SVB Securities reiterated a Buy rating on Replimune Group. The company’s shares closed last Tuesday at $19.59.

According to TipRanks.com, Chang is ranked 0 out of 5 stars with an average return of -12.7% and a 28.8% success rate. Chang covers the Healthcare sector, focusing on stocks such as Adaptimmune Therapeutics, Karyopharm Therapeutics, and Bicycle Therapeutics.

Replimune Group has an analyst consensus of Strong Buy, with a price target consensus of $49.33.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CNC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos